Westphal F

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases - Wagmann_2022_Arch.Toxicol__
Author(s) : Wagmann L , Stiller RG , Fischmann S , Westphal F , Meyer MR
Ref : Archives of Toxicology , : , 2022
Abstract : Wagmann_2022_Arch.Toxicol__
ESTHER : Wagmann_2022_Arch.Toxicol__
PubMedSearch : Wagmann_2022_Arch.Toxicol__
PubMedID: 35788413

Title : Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233 - Brandt_2021_Drug.Test.Anal_13_175
Author(s) : Brandt SD , Kavanagh PV , Westphal F , Dreiseitel W , Dowling G , Bowden MJ , Williamson JPB
Ref : Drug Test Anal , 13 :175 , 2021
Abstract : Brandt_2021_Drug.Test.Anal_13_175
ESTHER : Brandt_2021_Drug.Test.Anal_13_175
PubMedSearch : Brandt_2021_Drug.Test.Anal_13_175
PubMedID: 32880103

Title : How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae - Wagmann_2020_Front.Chem_8_539
Author(s) : Wagmann L , Frankenfeld F , Park YM , Herrmann J , Fischmann S , Westphal F , Muller R , Flockerzi V , Meyer MR
Ref : Front Chem , 8 :539 , 2020
Abstract : Wagmann_2020_Front.Chem_8_539
ESTHER : Wagmann_2020_Front.Chem_8_539
PubMedSearch : Wagmann_2020_Front.Chem_8_539
PubMedID: 32766204